Biopharmaceuticals
Drug Delivery
Litigation
Reimbursement
News Release - August 17, 2017
Mylan Finalizes Settlement Agreement on Medicaid Rebate Classification for EpiPen(R) Auto-Injector
Source: Mylan
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.